Khorsand M - Search Results

1

Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder.

Khorsand M, Lange J, Feun L, Clendeninn NJ, Collier M, Wilding G. Khorsand M, et al. Invest New Drugs. 1997;15(2):157-63. doi: 10.1023/a:1005860806635. Invest New Drugs. 1997. PMID: 9220296 Clinical Trial.

2

A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosis.

Hotton KM, Khorsand M, Hank JA, Albertini M, Kim KM, Wilding G, Salamat MS, Larson M, Sondel P, Schiller JH. Hotton KM, et al. Among authors: khorsand m. Cancer. 2000 Apr 15;88(8):1892-901. Cancer. 2000. PMID: 10760767 Clinical Trial.

3

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.

Schiller JH, Hank JA, Khorsand M, Storer B, Borchert A, Huseby-Moore K, Burns D, Wesly O, Albertini MR, Wilding G, Sondel PM. Schiller JH, et al. Among authors: khorsand m. Clin Cancer Res. 1996 Feb;2(2):319-30. Clin Cancer Res. 1996. PMID: 9816175 Clinical Trial.

4

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.

Albertini MR, Hank JA, Schiller JH, Khorsand M, Borchert AA, Gan J, Bechhofer R, Storer B, Reisfeld RA, Sondel PM. Albertini MR, et al. Among authors: khorsand m. Clin Cancer Res. 1997 Aug;3(8):1277-88. Clin Cancer Res. 1997. PMID: 9815810 Clinical Trial.

5

Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2.

Eastman ME, Khorsand M, Maki DG, Williams EC, Kim K, Sondel PM, Schiller JH, Albertini MR. Eastman ME, et al. Among authors: khorsand m. Cancer. 2001 Feb 15;91(4):806-14. Cancer. 2001. PMID: 11241250

6

Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations.

Hank JA, Surfus J, Gan J, Albertini M, Lindstrom M, Schiller JH, Hotton KM, Khorsand M, Sondel PM. Hank JA, et al. Among authors: khorsand m. Clin Cancer Res. 1999 Feb;5(2):281-9. Clin Cancer Res. 1999. PMID: 10037176 Clinical Trial.

7

Pathology in Practice.

Khorsand M, Martabano BB, MacNeill A, Ehrhart N, Dubielzig RR, Teixeira L, Henriksen ML. Khorsand M, et al. J Am Vet Med Assoc. 2022 Mar 12;259(S2):1-5. doi: 10.2460/javma.20.03.0155. J Am Vet Med Assoc. 2022. PMID: 35349472 Free article.

8

Multiple cerebral lesions complicating therapy with interleukin-2.

Karp BI, Yang JC, Khorsand M, Wood R, Merigan TC. Karp BI, et al. Among authors: khorsand m. Neurology. 1996 Aug;47(2):417-24. doi: 10.1212/wnl.47.2.417. Neurology. 1996. PMID: 8757014

9

Aptamer biosensors for thrombin.

Oushyani Roudsari Z, Ghasemi H, Khatami SH, Khorsand M, Rahdan F, Chehri D, Sheydaei O, Aiiashi S, Mahmoudi R, Movahedpour A. Oushyani Roudsari Z, et al. Among authors: khorsand m. Clin Chim Acta. 2025 Jan 15;565:119976. doi: 10.1016/j.cca.2024.119976. Epub 2024 Sep 24. Clin Chim Acta. 2025. PMID: 39321910 Review.

10

Circular RNAs in laryngeal cancer.

Razipour M, Jamali Z, Khorsand M, Zargar M, Maghsudlu M, Ghadami E, Shakoori A. Razipour M, et al. Among authors: khorsand m. Clin Chim Acta. 2025 Jan 1;564:119916. doi: 10.1016/j.cca.2024.119916. Epub 2024 Aug 15. Clin Chim Acta. 2025. PMID: 39153653 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters